Groupe PAT : PAT participe au projet européen de recherche « Bryomolécules »
16 déc. 2024 02h00 HE
|
Plant Advanced Technologies
Vandœuvre-lès-Nancy, le 16 décembre 2024 - 08 : 00 (CET) Communiqué de pressePour diffusion immédiate PAT participe au projet européen de recherche « Bryomolécules » Plant Advanced Technologies PAT...
BetterLife Announces Favorable Outcome in New York Legal Claims
09 déc. 2024 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of...
BetterLife Obtains Favourable Cardiac Safety Data for BETR-001
25 nov. 2024 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
31 oct. 2024 07h00 HE
|
SAB Biotherapeutics, Inc.
SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
PAT : Résultats semestriels 2024 non consolidés
30 oct. 2024 13h51 HE
|
Plant Advanced Technologies
Vandœuvre-lès-Nancy, le 30 octobre 2024 - 18 : 00 (CET) Communiqué de presse Pour diffusion immédiate Résultats semestriels 2024 de PATnon consolidés Résultats au 30 juin 2024 bénéficiaires...
Alvotech mun birta uppgjör fyrstu níu mánaða ársins miðvikudaginn 13. nóvember nk. og streyma uppgjörsfundi fimmtudaginn 14. nóvember nk. kl. 13:00 að íslenskum tíma
30 oct. 2024 08h30 HE
|
Alvotech
Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrir fyrstu níu mánuði ársins 2024 eftir lokun markaða í Bandaríkjunum, miðvikudaginn 13. nóvember nk. Þá mun Alvotech halda...
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
30 oct. 2024 08h30 HE
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release financial results for first nine months of...
SoCalBio Annual Investor & Partnering Conference Celebrates its 26th Successful Year as Greater Los Angeles’ Biotech/Medtech Industry’s Most Influential Event
29 oct. 2024 10h00 HE
|
Southern California Biomedical Council
LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Southern California Biomedical Council (SoCalBio) is proud to conclude the 2024 26th Annual Investor & Partnering Conference in Newport Beach, held...
BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001
23 oct. 2024 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
SoCalBio’s 26th Annual Two-Day Investor Partnership Conference hosted at the Hyatt Regency Newport Beach for the Medical Device and Biotechnology Industry
18 sept. 2024 13h14 HE
|
Southern California Biomedical Council
The Southern California Biomedical Council announced the full lineup of speakers and presenting companies for its 26th Annual SoCalBio Investor Conference.